Clinical trials remain the gold standard for proving a therapy works, but they show only part of the picture. Real-world evidence (RWE) fills the rest by showing how treatments perform across everyday patients, settings, and timeframes. Grand View Research values the global real world evidence solutions market at USD 3.0 billion in 2025, rising to USD 3.3 billion in 2026 and USD 6.0 billion by...